Ion channels are attractive drug targets due to their importance in health and disease, but finding ways to target a specific ion channel selectively is a major challenge.
Zentiva AG submits formal request to carry out a merger squeeze-out of the minority shareholders of APONTIS PHARMA AG – merger agreement planned – Biotech Investments
APONTIS PHARMA AG / Key word(s): Squeeze Out APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a merger squeeze-out of the minority
March 6, 2025